About
This stack combines CJC with ipamorelin in one formula, covering two GH-related signaling routes.
Key facts
- Two-compound GH-pathway blend
- CJC component aligns with GHRH-pathway signaling
- Ipamorelin component acts through the ghrelin receptor pathway
More product information
CJC aligns with GHRH-pathway signaling, while ipamorelin acts through the ghrelin receptor pathway, which is why the blend is commonly grouped as a dual-path GH stack.
- Growth Hormone Axis category
- Stack listing rather than single compound
- 20 mg total combined format
- Custom stack requests belong in custom review
